Concepedia

Author

Anne von Heideman

Uppsala University Hospital

Also Known As

A von Heideman, A. von Heideman, Anne Von Heideman, Anne von Heideman

10

Publications

339

Citations

7

H-Index

16

Concepts

All Affiliations

Uppsala University HospitalKarolinska InstitutetUppsala UniversitySophiahemmet HospitalUmeå University
AV

About

Anne von Heideman is an author at Uppsala University Hospital specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

242

2

Pharmacology

3

3

224

3

Cancer Therapeutics

3

3

221

4

Pathology

2

2

39

5

Obstetrics

1

1

18

Anne von Heideman

×

6

Publications

325

Citations

6

H-Index

YearCitations

Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data

Anne von Heideman, Åke Berglund, Rolf Larsson,

Cancer Chemotherapy and Pharmacology

2009

190

A Novel B-cell Line (U-2932) Established from a Patient with Diffuse Large B-cell Lymphoma Following Hodgkin Lymphoma

Rose‐Marie Amini, Mattias Berglund, Richard Rosenquist,

Leukemia & lymphoma/Leukemia and lymphoma

2002

61

Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986‐91

Erik Forestier, Göran Gustafsson, Anne von Heideman,

Acta Paediatrica

1997

22

Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis

Haile Mahteme, Anne von Heideman, Birgitta Grundmark,

European Journal of Surgical Oncology

2007

21

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma

Bengt Tholander, Anthoula Koliadi, Johan Botling,

Upsala Journal of Medical Sciences

2020

18

Selection of Chemotherapy by Ex Vivo Assessment of Tumor Sensitivity to Cytotoxic Drugs: Results of a Clinical Trial

Åke Berglund, Bengt Glimelius, Jonas Bergh,

Medical Oncology

2002

13

Page 1